References Yamamoto D, Ikeshita N, Matsubara T, Tasaki H, Herningtyas EH, Toda K, Iida K, Takahashi Y, Kaji H, Chihara K, Okimura Y
Guo Q, Jin Y, Chen X, Ye X, Shen X, Lin M, et al
Studies combining GLP-1 with muscle-protective agents demonstrate superior body composition outcomes compared to GLP-1 therapy alone, with better preservation of lean mass and improved metabolic parameters
Clarifying how these cytokines affect osteoblast activity can deepen our understanding of bone metabolism and guide the development of targeted therapies for inflammation-related bone disorders
Monitoring and patient counselling: Healthcare professionals should discuss contraceptive options before initiating Wegovy, particularly with patients who have obesity-related subfertility
One study found false daisy to absorb UVA and UVB radiation